against bacterial standard strains.
Erythromycin A (EM-A) has been one of the most useful macrolide antibiotics for the past three decades. In recent years, many derivatives of EM-Ahave been synthesized in order to improve antimicrobial activities and pharmacokinetics and also to reduce toxicities. 6-OMethylerythromycin A (TE-031), a new semisynthesized macrolide antibiotic, shows similar antimicrobial spectrum to EM-A,and in vitro activities of TE-031 are comparable or superior to those of EM-A. Furthermore, TE-031 exhibits excellent antimicrobial activities in vivo, because of its outstanding stability in acidic conditions and superior pharmacokinetic properties1"^.
In the course of studying metabolism of TE-031 in human, several urinary metabolites have been isolated4). Among them, three active metabolites, so-called M-5, M-6 and M-l, were determined as (14i?)-14-hydroxy-6-O-methylerythromycin A, (145)-14-hydroxy-6-0-methylerythromycin A and Ndemethvl-6-O-methvlervthromycin A, respectively, as shown in Fig. 1 .
Herein we wish to describe the structure determination of 14-hydroxy-6-0-methylerythromycins A (M-5 and M-6) and their antimicrobial activities.
Exper imental
In struments MP's were measured using a Yanaco micro mp apparatus and were uncorrected. IR spectra were recorded on a Jasco DS-701Gspectrometer. UVspectra were recorded on a Shimadzu UV-240 spectrophotometer. Optical rotations were measured with a Jasco DIP-181 digital polarimeter. Mass spectra were obtained with a Jeol JMS-DX3O3spectrometer.
XH and 13C NMR spectra were recorded on a Jeol JNM-GX400(XH 400 MHz, 13C 100.4 MHz) spectrometer. The signals of *H and 13C NMRspectra were assigned by correlated homonuclear^^H and heteronuclear XH-13C 2D NMRspectroscopies.
Source of Metabolites TE-031 was administered orally at 300 mg x2/day for 7.5 days to eight healthy volunteers. Approximately, 80 liters of urine were collected and used as the source of metabolites.
Thin-layer Bioautogram Approximately, 30 and 1 /ug of the crude residue, obtained by the EtOAc extraction of the urine, were applied to TLC plates (Silica gel 60 F254, 5 x20 cm, thickness 0.25 mm, Merck) and developed in a mobile phase composed of CHC13,MeOHand ammoniumhydroxide (9 : 1 :0.1). The air-dried TLC plates were laid on agar plates for 2 minutes which were inoculated with Micrococcus luteus ATCC 9341. The agar plates were incubated at 30°C for 18 hours for the detection of the active metabolites ofTE-031.
Antimicrobial Activity
The MICswere determined by means of an agar dilution method, using sensitivity test agar plates containing a series of 2-fold dilutions of sample. Overnight cultures in sensitivity test broth were used for precultures of tested strains. The MICs were determined after overnight incubation at 37°C, with an inoculum equivalent to a 10"2 dilution of an 18 hours culture in sensitivity test broth (about 106 cfu/ml). Each inoculum was seeded onto agar plates using an inoculum-replicating apparatus.
Results

Extraction and Isolation of Metabolites
The extraction and isolation procedure of the metabolites from urine are shownin Fig. 2 .
Urine was adjusted to pH 10 with aqueous sodium bicarbonate solution and extracted with EtOAc. The organic layer was filtered to remove the precipitates, washed with aqueous saturated sodium chloride solution and dried over magnesiumsulfate. Evaporation of the solvent afforded a crude residue (28.7g).
Thin-layer bioautogram of the residue is shown in Fig. 3 . Considerably active compounds, M-5 and the parent drug TE-031, were detected. In addition to these compounds, M-6 and M-l were also detected. By combination of silica gel column chromatography and crystallization, M-5 (2.39 g) was isolated as a major metabolite. M-6 (31 mg) and M-l (174 mg) were also obtained as minors.
Physico-chemical Properties of M-5 and M-6
Physico-chemical properties of M-5 and M-6 are shown in Table 1 . The XHand 13C NMRspectral data are listed in Tables 2, 3 Table 2 , the signal of 14-H in M-5 was observed at 4.13 ppm, which was considerably in lower field than that of TE-031. The peak of 15-H in M-5 was observed at 1.10 ppm, which was in lower field by 0.25 ppm as compared with that in TE-031. The splitting patterns for the signals of 13-H, 14-H and 15-H in M-5 were doublet, doublet of quartet and doublet, respectively, designating that C-14 was a methine carbon. The above results indicate that M-5 is 14-hydroxy TE-031. This is also supported by 13C NMRspectroscopic studies. The correlated heteronuclear 2H-13C 2D NMRspectroscopy of M-5 is shown in Fig. 5 . As shown in Table 4 , the chemical shifts of M-5 were also similar to those of TE-031 except for the signals of C-14 and C-15. In M-5 the observed down field shifts of C-14 (+45. 4 ppm) and C-15 (+9.2 ppm) with respect to TE- Detection: Micrococcus luteus ATCC9341. t'-h (y-cnB) a Coupling constants (/=Hz) were measured in CDC13at 400 MHz. 031 clearly pointed to C-14 as the site of hydroxylation, which were in good agreement with known substituent effects5 » 6).
The stereochemistry at C-14 in M-5 has been established to be R configuration. On the basis of the long range coupling experiment between C-21 (12-CH3) and 12-OH by correlated heteronuclear -"C 2D techniques, the hydroxy protons at 4.23 ppm (sharp) and 4.49 ppm (br) in M-5 were assigned to 12-OH and 14-OH, respectively, whereas 12-OH in TE-031 was observed at 3.18 ppm. The down field shift of 12-OH in M-5 suggested an intramolecular hydrogen bond between 12-OH and 14-OH. The coupling constant value between 13-H and 14-H in M-5 was /=9.2 Hz, indicating that 13-H was in relation to an tf«tf-staggered conformation with 14-H. Furthermore, nuclear Overhauser effect (NOE) enhancement was observed with 14-H on irradiation of 21-H (12-CH3). From the above results, the partial conformation around C-12~C-15~C-1 in M-5 is illustrated in Fig. 6 , and which closely resembles a comparable portion of the Perun conformation, model IH7). Therefore, M-5 was determined as (14i?)-14-hydroxy-6-<9-methylerythromycin A.
On the bases of FAB-MS and 13C NMR spectra, the molecular formula of M-6 was determined as C38H69NO14,which was the same as that of M-5. THE JOURNAL OF ANTIBIOTICS JULY 1988 Antimicrobial Activity
The in vitro antimicrobial activities of M-5 and M-6 against various standard strains are shown in Table 5 . M-5 was equal to or 2-fold less active than the parent drug (TE-031). M-6 was 4-to 8-fold less active than TE-031.
Discussion
As the macrolide antibiotics have poly functional structures, various types of metabolism have been reported. Concerning the metabolism of EM-A,iV-demethylation, cleavage of cladionose moiety and the formation of 6,9;9,12-spiroketal have been reported8~13). However, these metabolisms cause the inactivation of EM-A. We isolated (14R)-and (145>14-hydroxy-6-0-methylerythromycin A (M-5 and M-6) as active metabolites of TE-031 from urine of human. These structures were determined by means of mass, *H and 13C NMRspectroscopies.
The XHand 13C NMRassignments on M-5 and M-6 were made unambiguosly by homonuclear 1H-1H and heteronuclear 1H-18C 2D techniques, which were consistent with those reported on EM-Ain CDC1314). In Fisher projection, 14R (M-5) and 14S (M-6) are equivalent to 14d and 14l, respectively. Hydroxylation at C-14 is the first to be discovered in the metabolism of 14-memberedmacrolide antibiotics.
The metabolism of TE-031 in human is considerably different from that in animals. iV-Demethylation is a major metabolic pathway in rat and dog15), whereas 14-hydroxylation is a major one in human. From the viewpoint of antimicrobial activity, M-5 was equal to or 2-fold less active than TE-031 in vitro. Furthermore, M-5 was more effective than TE-031 against systemic infections in mice165. Because of the formation of M-5 in significant quantity in human and the excellent antimicrobial activities, M-5 gives distinctive features to TE-031.
